Consolidated Statements of Stockholders' Deficit (USD $)	Preferred Stock	Common Stock	Additional Paid in Capital, Preferred	Additional Paid in Capital, Common	Deferred Compensation	Accumulated Deficit	Total
Stockholders' Equity, Value at Jan. 31, 2013		$ 44,300		$ 2,562,578	$ (2,442,917)	$ (649,185)	$ (485,224)
Stockholders' Equity, Shares at Jan. 31, 2013		443,001
Issuance of preferred stock for patent, Value	2,500		5,262,500				5,265,000
Issuance of preferred stock for patent, Shares	2,500,000
Subsidiary spin-off						593,551	593,551
Amortization of stock options					2,084,167		2,084,167
Net loss						(7,836,907)	(7,836,907)
Stockholders' Equity, Value at Jan. 31, 2014	2,500	44,300	5,262,500	2,562,578	(358,750)	(7,892,541)	(379,413)
Stockholders' Equity, Shares at Jan. 31, 2014	2,500,000	443,001
Issuance of preferred stock for patent, Value
Conversion of debt to common stock, Value		455,000		(441,350)			13,650
Conversion of debt to common stock, Shares		4,550,000
Conversion of preferred stock to common stock, Value	(2,500)	2,500,000	(5,262,500)	2,765,000
Conversion of preferred stock to common stock, Shares	(2,500,000)	25,000,000
Grant of restricted stock award				1,040,000	(1,040,000)
Amortization of stock options					205,000		205,000
Vesting of restricted stock award, Value		65,000		(64,350)	740,000		740,650
Vesting of restricted stock award, Shares		650,000
Net loss						(1,090,336)	(1,090,336)
Stockholders' Equity, Value at Jan. 31, 2015		$ 3,064,300		$ 5,861,878	$ (453,750)	$ (8,982,877)	$ (510,449)
Stockholders' Equity, Shares at Jan. 31, 2015		30,643,001